Tag

Alopecia

All articles tagged with #alopecia

health7 days ago•6 min saved

Tirzepatide Might Trigger More Hair Loss Than Semaglutide, Early Study Suggests

A preprint study comparing tirzepatide (Zepbound/Mounjaro) with semaglutide (Ozempic/Wegovy) in 8,985 women found higher incident alopecia with tirzepatide (5.44% vs 3.63%). At six months, 1.55% vs 1.24%; at twelve months, 4.20% vs 2.88%. After adjusting for weight loss, hair loss remained more common with tirzepatide (4.24% vs 3.33%), suggesting weight loss alone doesn’t explain the difference. The study is observational and not yet peer‑reviewed. Experts note GLP-1 meds can cause temporary shedding, and persistent patches should be evaluated by a dermatologist; patients should not stop their medication without physician guidance. The differing receptor targets (GIP/GLP-1 for tirzepatide vs GLP-1 alone for semaglutide) may influence the hair follicle environment, but mechanisms are not yet clear.

via Women's Health|

#alopecia #glp-1 #hair-loss

health1 month ago•8 min saved

GLP-1 Meds May Trigger Rare Hair Loss, Study Finds

A BMJ study links GLP-1 diabetes/weight‑loss meds (semaglutide and tirzepatide) to a small but higher risk of non-scarring hair loss (alopecia) compared with SGLT-2 or DPP-4 therapies. After roughly 2.7 years, GLP-1 users had about 37% higher odds than SGLT-2 and 68% higher than DPP-4, with absolute rates of about 3–9 cases per 1,000 people per year. Hair shedding is usually non-permanent and may reflect telogen effluvium triggered by rapid weight loss or nutrient gaps; while the benefits of GLP-1 drugs remain substantial, patients should be aware of this potential trade-off and monitor for hair changes.

via The Daily Beast|

#alopecia #glp-1 #hair-loss

science1 month ago•13 min saved

Hair-loss risk linked to GLP-1 weight-loss drugs in large study

A BMJ study of about 50,000 patients finds that GLP-1 receptor agonists used for diabetes and obesity (Mounjaro, Wegovy, Ozempic) are linked to a higher risk of hair loss than other diabetes meds, with a 37% higher risk vs SGLT-2 inhibitors and 68% higher vs DPP-4 inhibitors; most hair loss is non-scarring and may relate to weight loss/caloric restriction and micronutrient changes, though regulators are reviewing safety signals; hair loss is usually not physically harmful but can affect quality of life.

via The Independent|

#alopecia #diabetes #glp-1-receptor-agonists

health1 month ago•2 min saved

GLP-1 Weight-Loss Drugs Show Small, Reversible Link to Hair Loss

A BMJ study of electronic health records finds GLP-1 receptor agonists, used for type 2 diabetes and obesity, are associated with a higher but still rare risk of alopecia compared with SGLT-2 and DPP-4 inhibitors; most cases are reversible as hair follicles remain intact; rapid weight loss and nutritional factors may contribute; the risk could affect patient satisfaction and adherence, and more research is needed to understand mechanisms and identify who is at greatest risk.

via Euronews.com|

#alopecia #diabetes #glp-1

health1 month ago•16 min saved

GLP-1 Weight-Loss Drugs May Bring Tiny Hair-Loss Risk

A Penn Medicine study of about 12,000 adults with type 2 diabetes newly started on GLP-1 drugs (including Ozempic and tirzepatide) found a small but higher risk of alopecia compared with users of other diabetes meds—about 1.6% developed hair loss over roughly two to three years, with GLP-1 users 37% more likely than SGLT-2 inhibitors and 68% more likely than DPP-4 inhibitors. The effect is mainly non-scarring and may be reversible; weight loss and possible nutrient deficiencies (iron, zinc) could drive a telogen effluvium mechanism. The study is observational and cannot prove causation; FDA labeling already lists alopecia as a potential adverse reaction, and ongoing dermatologic surveillance is advised.

via Gizmodo|

#alopecia #glp-1s #hair-loss

health1 month ago•5 min saved

New Study Flags Hair Loss Risk with GLP-1 Drugs

A BMJ study led by the University of Pennsylvania finds that GLP-1 receptor agonists used for obesity and type 2 diabetes are linked to a higher risk of non-scarring hair loss compared with SGLT-2 and DPP-4 inhibitors, though the absolute risk is small (about 7 in 1,000 per year). The researchers suggest rapid weight loss and nutritional changes as potential mechanisms and call for more research, while noting the need to weigh this potential side effect against the drugs’ benefits in shared decision-making.

via ScienceAlert|

#alopecia #bmj-study #glp-1-receptor-agonists

health2 months ago•5 min saved

Beyond Minoxidil: A multi-modal guide to boosting hair growth

Minoxidil remains effective but requires ongoing use and can cause scalp irritation or unwanted facial hair; experts review alternatives such as low-dose oral minoxidil, mesotherapy, rosemary oil, copper peptides, low-level laser therapy, PRP, saw palmetto, microneedling, ketoconazole shampoo, caffeine-based products, stem-cell therapies, and Regenera activa. These options often work best as part of a multi-modal plan that supports scalp health and the follicle environment rather than replacing minoxidil outright. Always consult a clinician for personalized guidance, and be aware of safety considerations like hormonal effects and pet toxicity from topical minoxidil.

via Vogue Arabia|

#alopecia #dermatology #hair-growth

science4 months ago•7 min saved

Protector Protein MCL-1 Could Enable Hair Regrowth

A Nature Communications study identifies MCL-1 as a cellular safeguard that lets activated hair follicle stem cells survive the stress of regrowth; without MCL-1, p53-driven cell death destroys the stem cells and halts hair regeneration, while blocking p53 can resume growth. ERBB signaling boosts MCL-1, and removing just one copy of the Bak gene can restore normal growth even without MCL-1, pointing to new therapeutic avenues for alopecia and broader insights into stem‑cell repair and cancer.

via SciTechDaily|

#alopecia #hair-follicle-stem-cells #hair-regeneration

health7 months ago•52 min saved

2026 Hair-Loss Treatments: proven therapies, new drugs, and promising trials

The Healthline piece surveys current and prospective hair‑loss treatments, highlighting established options finasteride and minoxidil as effective, affordable therapies, noting three FDA‑approved JAK inhibitors (Olumiant, Litfulo, Leqselvi) for alopecia areata with safety warnings, and surveying emerging approaches such as clascoterone, PP405, ET-02, stem-cell therapies, and fatty‑acid treatments. While these newer options show promise, many are still in early trials, and long‑term durability and safety remain uncertain. Experts emphasize early intervention and consulting ABHRS‑certified physicians for accurate diagnosis and personalized treatment planning.

via Healthline|

#alopecia #finasteride #hair-loss

science7 months ago•6 min saved

Deoxyribose Gel Prompts Hair Regrowth in Balding Mice

UK/Pakistan researchers report that a biodegradable gel made from the DNA sugar deoxyribose, when applied daily to shaved balding mice, triggered robust hair regrowth comparable to minoxidil, with no additional boost when combined with minoxidil; the effect is linked to increased blood supply to hair follicles, suggesting a potential new alopecia treatment, though findings are early and limited to male mice.

via ScienceAlert|

#alopecia #deoxyribose #hair-loss

entertainment10 months ago•3 min saved

Miss USA Contestant Embraces Alopecia in Bold Pageant Moment

Miss Nevada USA Mary Sickler, who has alopecia universalis, made a powerful statement during the Miss USA preliminaries by ditching her wig and wearing a bejeweled head covering, embracing her condition and promoting self-confidence and beauty beyond hair.

via AOL.com|

#alopecia #bravery #entertainment

health10 months ago•2 min saved

Sweetener Derived from Stevia Promises New Hope for Hair Regrowth

Research suggests that stevioside, a compound from Stevia, can enhance the delivery and effectiveness of minoxidil for hair regrowth, potentially leading to more natural and efficient treatments for alopecia, as demonstrated in mouse studies with a dissolving patch. Further research is needed to confirm safety and efficacy in humans.

via SciTechDaily|

#alopecia #hair-loss #health

health10 months ago•2 min saved

Stevia Compound Promises New Hope for Hair Regrowth

Researchers have found that stevioside, a natural compound from the Stevia plant, can enhance the absorption of minoxidil, a common hair loss treatment, leading to improved hair growth in a mouse model of alopecia. This discovery could lead to more effective and natural therapies for androgenetic alopecia, benefiting millions worldwide.

via ScienceDaily|

#absorption-enhancer #alopecia #hair-loss

music1 year ago•1 min saved

Molly Tuttle Explores New Directions in Bluegrass and Beyond

Molly Tuttle, a renowned bluegrass artist and Grammy winner, discusses her new album 'Crooked Tree,' her advocacy for alopecia awareness, and her experiences collaborating with artists like Ketch Secor and unexpectedly meeting Ringo Starr, highlighting her evolving musical style and personal journey.

via NPR|

#alopecia #bluegrass #crooked-tree

animal-welfare2 years ago•1 min saved

Shelter Rescuers Uncover Identity of Mystery Animal

A hairless raccoon was taken to a wildlife rehabilitation center in Nova Scotia, Canada, after a homeowner found her in their backyard. Rescuers discovered that the raccoon, named Rufus, was suffering from alopecia, causing her to lose all her fur. Despite her condition, Rufus has been accepted by other rescue raccoons and is being cared for by Hope For Wildlife. Rescuers are working to determine the cause of her alopecia and whether she can be released back into the wild in the future.

via The Dodo|

#alopecia #animal-rescue #animal-welfare